Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

The value of the calcium binding protein S100 in the management of patients with traumatic brain injury.

Schiavi P, Laccarino C, Servadei F.

Acta Biomed. 2012 Apr;83(1):5-20. Review.

PMID:
22978053
[PubMed - indexed for MEDLINE]
2.

Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury.

Filippidis AS, Papadopoulos DC, Kapsalaki EZ, Fountas KN.

Neurosurg Focus. 2010 Nov;29(5):E2. doi: 10.3171/2010.8.FOCUS10185. Review.

PMID:
21039136
[PubMed - indexed for MEDLINE]
3.

S100B is not a reliable prognostic index in paediatric TBI.

Piazza O, Storti MP, Cotena S, Stoppa F, Perrotta D, Esposito G, Pirozzi N, Tufano R.

Pediatr Neurosurg. 2007;43(4):258-64.

PMID:
17627141
[PubMed - indexed for MEDLINE]
4.

Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.

Hayakata T, Shiozaki T, Tasaki O, Ikegawa H, Inoue Y, Toshiyuki F, Hosotubo H, Kieko F, Yamashita T, Tanaka H, Shimazu T, Sugimoto H.

Shock. 2004 Aug;22(2):102-7.

PMID:
15257081
[PubMed - indexed for MEDLINE]
5.

GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.

Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H.

J Neurotrauma. 2004 Nov;21(11):1553-61.

PMID:
15684648
[PubMed - indexed for MEDLINE]
6.

Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.

Geyer C, Ulrich A, Gräfe G, Stach B, Till H.

J Neurosurg Pediatr. 2009 Oct;4(4):339-44. doi: 10.3171/2009.5.PEDS08481.

PMID:
19795965
[PubMed - indexed for MEDLINE]
7.

Differential effects of alcohol intoxication on S100B levels following traumatic brain injury.

Lange RT, Brubacher JR, Iverson GL, Procyshyn RM, Mitrovic S.

J Trauma. 2010 May;68(5):1065-71. doi: 10.1097/TA.0b013e3181bb9890.

PMID:
20016383
[PubMed - indexed for MEDLINE]
8.

Serum S100B protein in early management of patients after mild traumatic brain injury.

Morochovic R, Rácz O, Kitka M, Pingorová S, Cibur P, Tomková D, Lenártová R.

Eur J Neurol. 2009 Oct;16(10):1112-7. doi: 10.1111/j.1468-1331.2009.02653.x. Epub 2009 May 12.

PMID:
19469828
[PubMed - indexed for MEDLINE]
9.

Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h.

Gonzćlez-Mao MC, Repáraz-Andrade A, Del Campo-Pérez V, Alvarez-García E, Vara-Perez C, Andrade-Olivié MA.

Clin Lab. 2011;57(7-8):587-97.

PMID:
21888023
[PubMed - indexed for MEDLINE]
10.

GFAP and S100B in the acute phase of mild traumatic brain injury.

Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J.

Neurology. 2012 May 1;78(18):1428-33. doi: 10.1212/WNL.0b013e318253d5c7. Epub 2012 Apr 18.

PMID:
22517109
[PubMed - indexed for MEDLINE]
11.

Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury.

Kleindienst A, Meissner S, Eyupoglu IY, Parsch H, Schmidt C, Buchfelder M.

Acta Neurochir Suppl. 2010;106:247-50. doi: 10.1007/978-3-211-98811-4_46.

PMID:
19812958
[PubMed - indexed for MEDLINE]
12.

Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury.

Nylén K, Ost M, Csajbok LZ, Nilsson I, Hall C, Blennow K, Nellgård B, Rosengren L.

Acta Neurochir (Wien). 2008 Mar;150(3):221-7; discussion 227. doi: 10.1007/s00701-007-1489-2. Epub 2008 Jan 14.

PMID:
18193148
[PubMed - indexed for MEDLINE]
13.

Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.

Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, Kochanek PM.

Pediatrics. 2002 Feb;109(2):E31.

PMID:
11826241
[PubMed - indexed for MEDLINE]
14.

The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury.

Žurek J, Fedora M.

Acta Neurochir (Wien). 2012 Jan;154(1):93-103; discussion 103. doi: 10.1007/s00701-011-1175-2.

PMID:
21976236
[PubMed - indexed for MEDLINE]
15.

Effects of head and extracranial injuries on serum protein S100B levels in trauma patients.

Savola O, Pyhtinen J, Leino TK, Siitonen S, Niemelä O, Hillbom M.

J Trauma. 2004 Jun;56(6):1229-34; discussion 1234.

PMID:
15211130
[PubMed - indexed for MEDLINE]
16.

Cerebrospinal s100-B: a potential marker for progressive intracranial hemorrhage in patients with severe traumatic brain injury.

Kirchhoff C, Buhmann S, Braunstein V, Leidel BA, Vogel T, Kreimeier U, Mutschler W, Biberthaler P.

Eur J Med Res. 2008 Nov 24;13(11):511-6.

PMID:
19073387
[PubMed - indexed for MEDLINE]
17.

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.

Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM.

Neurology. 2004 Apr 27;62(8):1303-10.

PMID:
15111666
[PubMed - indexed for MEDLINE]
18.

Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point.

Rainey T, Lesko M, Sacho R, Lecky F, Childs C.

Resuscitation. 2009 Mar;80(3):341-5. doi: 10.1016/j.resuscitation.2008.11.021. Epub 2009 Jan 15.

PMID:
19150161
[PubMed - indexed for MEDLINE]
19.

S100B serum level predicts computed tomography findings after minor head injury.

Müller K, Townend W, Biasca N, Undén J, Waterloo K, Romner B, Ingebrigtsen T.

J Trauma. 2007 Jun;62(6):1452-6.

PMID:
17563665
[PubMed - indexed for MEDLINE]
20.

[S100B protein and autoantibodies to S100B protein in diagnostics of brain damage in craniocerebral trauma in children].

Sorokina EG, Semenova ZhB, Granstrem OK, Karaseva OV, Meshcheriakov SV, Reutov VP, Sushkevich GN, Pinelis VG, Roshal' LM.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(8):30-5. Russian.

PMID:
20823827
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk